| Literature DB >> 21291558 |
Valerie Smith1, Declan Devane, Cecily M Begley, Mike Clarke.
Abstract
BACKGROUND: Hundreds of studies of maternity care interventions have been published, too many for most people involved in providing maternity care to identify and consider when making decisions. It became apparent that systematic reviews of individual studies were required to appraise, summarise and bring together existing studies in a single place. However, decision makers are increasingly faced by a plethora of such reviews and these are likely to be of variable quality and scope, with more than one review of important topics. Systematic reviews (or overviews) of reviews are a logical and appropriate next step, allowing the findings of separate reviews to be compared and contrasted, providing clinical decision makers with the evidence they need.Entities:
Mesh:
Year: 2011 PMID: 21291558 PMCID: PMC3039637 DOI: 10.1186/1471-2288-11-15
Source DB: PubMed Journal: BMC Med Res Methodol ISSN: 1471-2288 Impact factor: 4.615
Summary table of scope of reviews in a systematic review of reviews1
| Review | Aim (participants) | Search strategy | No. of studies included | Total no. of participants | Timing of preventative strategy |
|---|---|---|---|---|---|
| King & Flenady 2002 | To assess the effects of prophylactic antibiotics on preterm labour (women symptomatic for preterm labour) | Cochrane Pregnancy & Childbirth Group (May 2002) | 11 | 7428 (6295 enrolled in one trial) | Mean gestational age at entry to all trials 30-32 weeks (but varied across studies) |
| Simcox et al 2007 | To determine if antibiotics reduce the risk of preterm birth (asymptomatic women at risk, e.g. previous preterm birth or positive fibronectin status) | Cochrane Pregnancy & Childbirth Group (2005) | 17 | 1291 | 12-28 weeks across studies |
1Reprinted from the European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 142, Smith V, Devane D, Begley CM, Clarke M, Higgins S. A systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. 3-11, Copyright (2009), with permission from Elsevier.
Summary of results reported in a systematic review of reviews2
| Review | Tocolytic agent | Birth >48 hrs (95% CI) | Birth >7 days | Birth >34 weeks | Birth >37 weeks |
|---|---|---|---|---|---|
| King 1988 | Betamimetics compared with placebo or no treatment | 12 trials | - | - | 8 trials |
| Coomarasamy et al 2002 | Atosiban V placebo (2 trials) | 2 trials | - | - | - |
| Crowther et al 2002 | Magnesium sulphate V placebo/no treatment or other tocolytic agent | 11 trials | - | No difference reported | No difference reported |
| King et al 2003 | Calcium channel blockers V any other tocolytic agent | - | RR 0.76, (0.60-0.97) | RR 0.83, (0.69-0.99) | RR 0.95, (0.83-1.09) |
| Anotayanonth et al 2004 | Betamimetics V Placebo | 11 trials | 11 trials | - | 11 trials |
| King et al 2005 | COX inhibitor V Placebo | 2 trials | 2 trials | - | 3 trials |
| Whitworth & Quenby 2008 | Oral betamimetic V placebo | - | - | - | RR 1.07, |
2 Reprinted from the European Journal of Obstetrics & Gynecology and Reproductive Biology, Volume 142, Smith V, Devane D, Begley CM, Clarke M, Higgins S. A systematic review and quality assessment of systematic reviews of randomised trials of interventions for preventing and treating preterm birth. 3-11, Copyright (2009), with permission from Elsevier.